Trending Topics
Zoll header_$.png

Nationwide, communities continue to battle the effects of the opioid crisis. Litigation brought by states against drug distributors, manufacturers and pharmacy chains has produced opioid settlement funding designed to bring relief to communities affected by the epidemic. The various funding mechanisms (how to request, how to apply and to who) is evolving and varies by state.

First responders are on the front line of this crisis treating overdose patients, securing illegal, dangerous drugs and managing the various scenarios related to opioid calls. For public safety agencies, including EMS, opioid settlement funding may be tapped for a variety of purposes. For this reason, public safety leaders must understand the basics of the settlements, how funds will be distributed and how your agency may be able to tap into funding in a responsible manner.

Follow our Opioid Settlement Funding: Compensation For Communities coverage, brought to you by ZOLL Medical, to stay informed.

Related news about the opioid crisis and improving patient outcomes
Successful substance abuse treatment requires evidence-based practices, individualized care and program components tailored to unique needs of EMTs and paramedics
The 20-year-old woman was hiking with three friends when she became lethargic and couldn’t walk or talk
Statewide, deaths from heroin overdoses increased from 239 in 2013 to 342 last year
The judge set a $20,000 cash-only bond
In 2014, Manatee County led all 67 counties in heroin overdose deaths per capita
Paramedics and EMTs have used over 45 percent more anti-overdose medical kits than last year
A two-pack of the Narcan nasal spray sells for about $150, which includes a counseling session on how to recognize the signs of an overdose and how to use the product
Improving ePCR systems make it easier to capture, share, monitor and analyze big data for better local and national patient care
The video is making the rounds on social media, renewing the discussion about the region’s heroin epidemic and the community’s response
About the Sponsor: ZOLL
ZOLL is a resuscitation solutions pioneer, distinguished by consistency in management, ownership, and approach for nearly 30 years. As a financially strong, public company, ZOLL has an enviable product quality and reliability record. ZOLL technologies to help advance the practice of resuscitation include pacing, defibrillation, circulation, ventilation, data management, and fluid resuscitation.

These comprehensive technologies help clinicians, EMS professionals, and lay rescuers resuscitate sudden cardiac arrest and trauma victims. ZOLL’s commitment is to be the dependable choice for all providers in the field of resuscitation.

ZOLL markets and sells its products, including AED Plus®, AED Pro®, the R Series™ defibrillator, the AutoPulse® non-invasive cardiac support pump, and the LifeVest® wearable defibrillator in more than 140 countries. The Company has direct operations, distributor networks, and business partners throughout the U.S., Canada, Latin America, Europe, the Middle East and Africa, Asia, and Australia.